Thymopoietin (TMPO) (Middle Region) Peptide
TMPO
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Thymopoietin (TMPO) products
- Thymopoietin (TMPO)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TMPO antibody (Catalog #: ARP44800_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Thymopoietin (TMPO)
- Background
-
TMPO may be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. It plays an important role, together with LMNA, in the nuclear anchorage of RB1.
Alias Symbols: CMD1T, LAP2, MGC61508, PRO0868, TP, LEMD4
Protein Interaction Partner: RB1,AKAP8L,BANF1,GMCL1,LMNA,LMNB1,RB1,SGTA,SGTB,USP7,AKAP8L,BANF1,Gmcl1,LMNA,LMNB1,LMNB2,RB1
Protein Size: 345 - Molecular Weight
- 39 kDa
- Gene ID
- 7112
- NCBI Accession
- NM_001032284, NP_001027455
-
You are here:
